Skip to main content

Advertisement

Log in

Does treatment with t-PA increase the risk of developing epilepsy after stroke?

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Patients suffering from ischemic stroke carry an enhanced risk of developing secondary epilepsy. We sought to clarify whether thrombolytic treatment with recombinant tissue plasminogen activator (t-PA) is independently associated with post-stroke epilepsy (PSE). In this observational study, data from 302 stroke patients treated at a single academic neurological department were analyzed retrospectively. Median follow-up was 42 months (maximum 80). Variables included presence of comorbidity, stroke severity, neurological presentation, complications, infarct characteristics, and treatment with t-PA. After univariate analyses, a multivariate analysis was performed to create a model of factors that were significantly associated with PSE, including treatment with t-PA. 13.9 % of patients developed PSE during follow-up. Multivariate analysis identified 5 independent factors for PSE: low Barthel Index at discharge; hemianopia; infection acquired during the hospital stay; involvement of the temporal lobe; involvement of the perirolandic cortex. While the incidence of PSE was higher in patients treated with t-PA (20.6 vs. 10.7 %, univariate analysis; p = 0.020), the effect was lost after adjusting for several factors associated with t-PA treatment [odds ratio for PSE after treatment with t-PA 1.3 (95 % CI 0.6–2.9), p = 0.489]. This study failed to identify treatment with t-PA as an independent risk factor for PSE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Sander JW, Hart YM, Johnson AL et al (1990) National General Practice Study of Epilepsy:newly diagnosed epileptic seizures in a general population. Lancet 336(8726):1267–1271

    Article  CAS  PubMed  Google Scholar 

  2. Roberts MA, Godfrey JW, Caird FI (1982) Epileptic seizures in the elderly: I. aetiology and type of seizure. Age Ageing 11(1):24–28

    Article  CAS  PubMed  Google Scholar 

  3. So EL, Annegers JF, Hauser WA et al (1996) Population-based study of seizure disorders after cerebral infarction. Neurology 46(2):350–355

    Article  CAS  PubMed  Google Scholar 

  4. Bladin CF, Alexandrov AV, Bellavance A et al (2000) Seizures after stroke. A prospective multicenter study. Arch Neurol 57(11):1617–1622

    Article  CAS  PubMed  Google Scholar 

  5. Camilo O, Goldstein LB (2004) Seizures and epilepsy after ischemic stroke. Stroke 35(7):1769–1775. doi:10.1161/01.STR.0000130989.17100.96

    Article  PubMed  Google Scholar 

  6. Myint PK, Staufenberg EFA, Sabanathan K (2006) Post-stroke seizure and post-stroke epilepsy. Postgrad Med J 82(971):568–572. doi:10.1136/pgmj.2005.041426

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Menon B, Shorvon SD (2009) Ischaemic stroke in adults and epilepsy. Epilepsy Res 87(1):1–11. doi:10.1016/j.eplepsyres.2009.08.007

    Article  PubMed  Google Scholar 

  8. Arntz RM, Maaijwee NAM, Rutten-Jacobs LCA et al (2013) Epilepsy after TIA or stroke in young patients impairs long-term functional outcome: the FUTURE Study. Neurology 81(22):1907–1913. doi:10.1212/01.wnl.0000436619.25532.f3

    Article  PubMed  Google Scholar 

  9. Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329. doi:10.1056/NEJMoa0804656

    Article  CAS  PubMed  Google Scholar 

  10. Saver JL, Fonarow GC, Smith EE et al (2013) Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 309(23):2480–2488. doi:10.1001/jama.2013.6959

    Article  CAS  PubMed  Google Scholar 

  11. Stolz E, Hamann GF, Kaps M et al (2011) Regional differences in acute stroke admission and thrombolysis rates in the German federal state of Hesse. Dtsch Arztebl Int 108(36):607–611. doi:10.3238/arztebl.2011.0607

    PubMed Central  PubMed  Google Scholar 

  12. Goto H, Fujisawa H, Oka F et al (2007) Neurotoxic effects of exogenous recombinant tissue-type plasminogen activator on the normal rat brain. J Neurotrauma 24(4):745–752. doi:10.1089/neu.2006.0183

    Article  PubMed  Google Scholar 

  13. Lemarchant S, Docagne F, Emery E et al (2012) tPA in the injured central nervous system:different scenarios starring the same actor? Neuropharmacology 62(2):749–756. doi:10.1016/j.neuropharm.2011.10.020

    Article  CAS  PubMed  Google Scholar 

  14. Harston GWJ, Sutherland BA, Kennedy J et al (2010) The contribution of l-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia:a review of rtPA neurotoxicity. J Cereb Blood Flow Metab 30(11):1804–1816. doi:10.1038/jcbfm.2010.149

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Samson AL, Medcalf RL (2006) Tissue-type plasminogen activator:a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 50(5):673–678. doi:10.1016/j.neuron.2006.04.013

    Article  CAS  PubMed  Google Scholar 

  16. de Reuck J, van Maele G (2010) Acute ischemic stroke treatment and the occurrence of seizures. Clin Neurol Neurosurg 112(4):328–331. doi:10.1016/j.clineuro.2010.01.004

    Article  PubMed  Google Scholar 

  17. Roivainen R, Haapaniemi E, Putaala J et al (2013) Young adult ischaemic stroke related acute symptomatic and late seizures:risk factors. Eur J Neurol 20(9):1247–1255. doi:10.1111/ene.12157

    Article  CAS  PubMed  Google Scholar 

  18. Alvarez V, Rossetti AO, Papavasileiou V et al (2013) Acute seizures in acute ischemic stroke:does thrombolysis have a role to play? J Neurol 260(1):55–61. doi:10.1007/s00415-012-6583-6

    Article  PubMed  Google Scholar 

  19. Creutzfeldt CJ, Tirschwell DL, Kim LJ et al (2013) Seizures after decompressive hemicraniectomy for ischaemic stroke. J Neurol Neurosurg Psychiatr. doi:10.1136/jnnp-2013-305678

    PubMed  Google Scholar 

  20. Tan M, Ng A, Pandher PS et al (2012) Tissue plasminogen activator does not alter development of acquired epilepsy. Epilepsia 53(11):1998–2004. doi:10.1111/j.1528-1167.2012.03635.x

    Article  CAS  PubMed  Google Scholar 

  21. Rodan LH, Aviv RI, Sahlas DJ et al (2006) Seizures during stroke thrombolysis heralding dramatic neurologic recovery. Neurology 67(11):2048–2049. doi:10.1212/01.wnl.0000247231.25231.2e

    Article  CAS  PubMed  Google Scholar 

  22. Stefan H (2011) Epilepsy in the elderly:facts and challenges. Acta Neurol Scand 124(4):223–237. doi:10.1111/j.1600-0404.2010.01464.x

    Article  CAS  PubMed  Google Scholar 

  23. Fisher RS, van Emde Boas W, Blume W et al (2005) Epileptic seizures and epilepsy:definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46(4):470–472. doi:10.1111/j.0013-9580.2005.66104.x

    Article  PubMed  Google Scholar 

  24. Hamidou B, Aboa-Eboulé C, Durier J et al (2013) Prognostic value of early epileptic seizures on mortality and functional disability in acute stroke:the Dijon Stroke Registry (1985–2010). J Neurol 260(4):1043–1051. doi:10.1007/s00415-012-6756-3

    Article  PubMed  Google Scholar 

  25. Sacco RL, Kasner SE, Broderick JP et al (2013) An updated definition of stroke for the 21st century:a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(7):2064–2089. doi:10.1161/STR.0b013e318296aeca

    Article  PubMed  Google Scholar 

  26. Gupta SR, Naheedy MH, Elias D et al (1988) Postinfarction seizures. A clinical study. Stroke 19(12):1477–1481

    Article  CAS  PubMed  Google Scholar 

  27. Kretschmann H, Weinrich W (2004) Cranial neuroimaging and clinical neuroanatomy. Atlas of MR imaging and computed tomography, 3rd edn. Georg Thieme Verlag; Thieme Medical Publishers, Stuttgart, New York

  28. Pellkofer T (2004) Progressive lakunäre Schlaganfälle: Pathophysiologie, Verlauf und Prognose. Dissertation, Ludwig-Maximilians-Universität

  29. von Kummer R, Allen KL, Holle R et al (1997) Acute stroke:usefulness of early CT findings before thrombolytic therapy. Radiology 205(2):327–333. doi:10.1148/radiology.205.2.9356611

    Article  Google Scholar 

  30. Naess H, Nyland HI, Thomassen L et al (2004) Long-term outcome of cerebral infarction in young adults. Acta Neurol Scand 110(2):107–112. doi:10.1111/j.1600-0404.2004.00273.x

    Article  CAS  PubMed  Google Scholar 

  31. de Reuck J, Goethals M, Vonck K et al (2005) Clinical predictors of late-onset seizures and epilepsy in patients with cerebrovascular disease. Eur Neurol 54(2):68–72. doi:10.1159/000087715

    Article  PubMed  Google Scholar 

  32. Fukujima MM, Cardeal JO (1997) Características das crises epilépticas após acidente vascular cerebral isquêmico (Characteristics of epileptic seizures after ischemic stroke). Arq Neuropsiquiatr 55(4):741–748

    Article  CAS  PubMed  Google Scholar 

  33. Lossius MI, Rønning OM, Slapø GD et al (2005) Poststroke epilepsy:occurrence and predictors–a long-term prospective controlled study (Akershus Stroke Study). Epilepsia 46(8):1246–1251. doi:10.1111/j.1528-1167.2005.57904.x

    Article  PubMed  Google Scholar 

  34. Strzelczyk A, Haag A, Raupach H et al (2010) Prospective evaluation of a post-stroke epilepsy risk scale. J Neurol 257(8):1322–1326. doi:10.1007/s00415-010-5520-9

    Article  PubMed  Google Scholar 

  35. Boovalingam P, Witherall R, Ho CL et al (2012) Post-stroke epilepsy. GM (Geriatric Medcine)

  36. Szilágyi G, Vas A, Kerényi L et al (2012) Correlation between crossed cerebellar diaschisis and clinical neurological scales. Acta Neurol Scand 125(6):373–381. doi:10.1111/j.1600-0404.2011.01576.x

    Article  PubMed  Google Scholar 

  37. Infeld B, Davis SM, Lichtenstein M et al (1995) Crossed Cerebellar Diaschisis and Brain Recovery After Stroke. Stroke 26(1):90–95. doi:10.1161/01.STR.26.1.90

    Article  CAS  PubMed  Google Scholar 

  38. Ferro JM, Pinto F (2004) Poststroke epilepsy:epidemiology, pathophysiology and management. Epidemiology, Pathophysiology and Management. Drugs Aging 21(10):639–653

    Article  CAS  PubMed  Google Scholar 

  39. Graham NSN, Crichton S, Koutroumanidis M et al (2013) Incidence and associations of poststroke epilepsy:the prospective South London Stroke Register. Stroke 44(3):605–611. doi:10.1161/STROKEAHA.111.000220

    Article  PubMed  Google Scholar 

  40. Heuts-van Raak L, Lodder J, Kessels F (1996) Late seizures following a first symptomatic brain infarct are related to large infarcts involving the posterior area around the lateral sulcus. Seizure 5(3):185–194

    Article  CAS  PubMed  Google Scholar 

  41. Heuts-Van Raak EP, Boellaard A, de Krom MC et al (1993) Supratentorial brain infarcts in adult-onset seizures; the Maastricht Epilepsy Case Register. Seizure 2(3):221–227

    Article  CAS  PubMed  Google Scholar 

  42. Arboix A, Comes E, Massons J et al (1996) Relevance of early seizures for in-hospital mortality in acute cerebrovascular disease. Neurology 47(6):1429–1435

    Article  CAS  PubMed  Google Scholar 

  43. Pezzini A, Grassi M, Del Zotto E et al (2013) Complications of acute stroke and the occurrence of early seizures. Cerebrovasc. Dis. 35(5):444–450. doi:10.1159/000348704

    Article  CAS  PubMed  Google Scholar 

  44. Huang C, Saposnik G, Fang J et al (2014) Influence of seizures on stroke outcomes:a large multicenter study. Neurology 82(9):768–776. doi:10.1212/WNL.0000000000000166

    Article  PubMed  Google Scholar 

  45. Kuntz M, Mysiorek C, Pétrault O et al (2014) Transient oxygen-glucose deprivation sensitizes brain capillary endothelial cells to rtPA at 4 h of reoxygenation. Microvasc Res 91:44–57. doi:10.1016/j.mvr.2013.12.002

    Article  CAS  PubMed  Google Scholar 

  46. An J, Haile WB, Wu F et al (2014) Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system. Neuroscience 257:41–48. doi:10.1016/j.neuroscience.2013.10.060

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. Kelly MA, Shuaib A, Todd KG (2006) Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis. Exp Neurol 200(1):38–49. doi:10.1016/j.expneurol.2006.01.032

    Article  CAS  PubMed  Google Scholar 

  48. Adibhatla RM, Hatcher JF (2008) Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke:therapeutic strategies. CNS Neurol Disord: Drug Targets 7(3):243–253

    Article  CAS  Google Scholar 

  49. Hobohm C, Günther A, Grosche J et al (2005) Decomposition and long-lasting downregulation of extracellular matrix in perineuronal nets induced by focal cerebral ischemia in rats. J Neurosci Res 80(4):539–548. doi:10.1002/jnr.20459

    Article  CAS  PubMed  Google Scholar 

  50. Liu D, Cheng T, Guo H et al (2004) Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat Med 10(12):1379–1383. doi:10.1038/nm1122

    Article  CAS  PubMed  Google Scholar 

  51. Su EJ, Fredriksson L, Geyer M et al (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14(7):731–737. doi:10.1038/nm1787

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  52. Jin R, Yang G, Li G (2010) Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke:critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis 38(3):376–385. doi:10.1016/j.nbd.2010.03.008

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Parathath SR, Parathath S, Tsirka SE (2006) Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice. J Cell Sci 119(Pt 2):339–349. doi:10.1242/jcs.02734

    Article  CAS  PubMed  Google Scholar 

  54. Lee H, Hwang I, Im H et al (2007) Non-proteolytic neurotrophic effects of tissue plasminogen activator on cultured mouse cerebrocortical neurons. J Neurochem 101(5):1236–1247. doi:10.1111/j.1471-4159.2007.04417.x

    Article  CAS  PubMed  Google Scholar 

  55. Hauser WA, Annegers JF, Kurland LT (1993) Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota:1935-1984. Epilepsia 34(3):453–468

    Article  CAS  PubMed  Google Scholar 

  56. Conrad J, Pawlowski M, Dogan M et al (2013) Seizures after cerebrovascular events:risk factors and clinical features. Seizure 22(4):275–282. doi:10.1016/j.seizure.2013.01.014

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Petra Baum.

Ethics declarations

Conflict of interest

The authors disclose any conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Keller, L., Hobohm, C., Zeynalova, S. et al. Does treatment with t-PA increase the risk of developing epilepsy after stroke?. J Neurol 262, 2364–2372 (2015). https://doi.org/10.1007/s00415-015-7850-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-015-7850-0

Keywords

Navigation